MAIA Biotechnology, Inc. (MAIA) Raises $695K in Private Placement to Advance Cancer Trial
MAIA Biotechnology, Inc. (NYSE:MAIA), a clinical-stage biopharmaceutical company, has announced a private placement agreement to raise approximately $695,000.
Maia Biotechnology Inc. (MAIA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.69 | 2,700 | $9,958.68 | 1,424,178 | 2022-09-19 | Filing | |
| $1.22 | 57,189 | $69,999.34 | 1,421,478 | 2025-12-22 | Filing | |
| $1.22 | 40,849 | $49,999.18 | 151,873 | 2025-12-22 | Filing | |
| $1.22 | 81,699 | $99,999.58 | 1,248,888 | 2025-12-22 | Filing | |
| $1.20 | 4,580 | $5,496.00 | 4,580 | 2025-12-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,154,833 | $1,766,895 | 0% | |
| 2. | 586,398 | $1,137,612 | 0.24% | |
| 3. | 296,740 | $454,107 | 0% | |
| 4. | 107,245 | $164,085 | 0% | |
| 5. | 78,757 | $120,498 | 0% |
News See All
Hedge Fund Resource Center